Rethinking ADHD | Qbtech

Trauma, autism, anxiety, or sleep problems; many patients present with overlapping conditions that muddy the diagnostic waters. In this episode, our ADHD experts unpack how clinicians can use a comorbidity-informed lens to interpret assessments, including objective tools such as QbCheck.Plus, they explore triage strategies that protect patient safety without overloading the system. To watch the podcast instead, check out our YouTube channel: https://bit.ly/4uycroD

In this episode, our clinical expert Jess Brunet is in conversation with Ceri Reed, Founder of Parents Voices in Wales CIC, and Penny Lazell, Senior Clinical Advisor at Qbtech. They explore what “holistic ADHD care” really means and why a comprehensive approach can transform outcomes for patients.Whether you’re a mental‑health professional, clinician, ADHD advocate, or someone interested in improving ADHD care, this episode is for you.To watch the podcast: https://bit.ly/4bZCHQY

In this episode of Rethinking ADHD, Dr James Wiley MD and Dr David Aversa, MD, MPH joined Qbtech’s Head of Clinical Research, Ragini Sanyal, to unpack what modern medication management looks like and how tools like QbCheck are helping clinicians titrate with greater clarity and confidence. Speaker info: Dr James Wiley, MD, FocusMD Dr David Aversa, MD, MPH, CT Psych and Wellness/BeaconRagini Sanyal, Head of Clinical Research, QbtechWant to understand the correlation between titration and objective data? Want episodes like this in your inbox? Join the Rethinking ADHD community 

ADHD goes beyond inattention and hyperactivity. It affects emotions, relationships, careers, and daily life in ways that many, even those living with ADHD, may not fully understand. This episode of our ADHD podcast series covers the realities of experiencing neurodivergence, including delayed diagnoses, difficulties with emotional dysregulation, coping strategies and the importance of a clinician’s role in a patient's ADHD care journey.  The conversation between Duane Gordon, President of ADDA, Helen Turnbull, Evelyn Polk-Green, Ex President of ADDA, and Katie Hathaway, M.S, BCBA, is one of honesty, humor, and insight, offering a deeper understanding of ADHD that textbooks often miss.

ADHD is a neurodevelopmental disorder, meaning symptoms must have been present since childhood (APA, DSM-5). Understanding a patient’s early development is critical when assessing and treating ADHD. A thorough developmental history helps clinicians differentiate symptoms from comorbid conditions like autism, learning disorders, or anxiety.The latest webinar, led by our clinical experts Jess Brunett, Ryan Martin, and Penny Lazell, delves into the critical role data gathering and developmental history play in an ADHD diagnosis.

In this webinar, our clinical advisors Jess Brunet (advanced nurse practitioner and non-medical prescriber in the UK) and Ryan Martin (former neuropsych tech and autism practitioner in the US) delve into the complexities of differentiating between ADHD and ASD. The discussion highlights overlapping symptoms, diagnostic challenges, and strategies for accurate differentiation, particularly in pediatric and adult populations.